Lonza unrolls Bioscience strategy
Article Abstract:
Lonza unveiled its business strategy for its new Bioscience division. The company projected making several investments for the said division which will be comprised of four business units: Rapid Testing Systems, Cell Therapy, Media and Cell Discovery, and Molecular Biology. Company forecasts and sales are also discussed.
Publication Name: Speciality Chemicals
Subject: Chemicals, plastics and rubber industries
ISSN: 0262-2262
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Aptuit adds on Evotec CPD
Article Abstract:
Aptuit is acquiring Germany-based Evotec's UK-based Chemical & Pharmaceutical Development (CPD) business . The deal, which is worth around 46.4 mil lion euros, will close by the end of November 2008 and it involves the transfer of e mployees and facilities worldwide. The scope of the deal is discussed.
Publication Name: Speciality Chemicals
Subject: Chemicals, plastics and rubber industries
ISSN: 0262-2262
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: ICI: a chemicals icon exits the stage. DSM buys Pentapharm
- Abstracts: EFCG demands excipient standards. When is an off-patent product not a generic?
- Abstracts: Infrared study of the effect of hydration on the amide I band and aggregation properties of helical peptides. On the temperature dependence of amide I frequencies of peptides in solution